Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

7.7%

49 terminated/withdrawn out of 639 trials

Success Rate

86.4%

-0.1% vs industry average

Late-Stage Pipeline

8%

51 trials in Phase 3/4

Results Transparency

0%

0 of 311 completed trials have results

Key Signals

102 recruiting48 terminated

Enrollment Performance

Analytics

N/A
171(71.3%)
Phase 3
46(19.2%)
Phase 2
13(5.4%)
Phase 1
5(2.1%)
Phase 4
5(2.1%)
240Total
N/A(171)
Phase 3(46)
Phase 2(13)
Phase 1(5)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (639)

Showing 20 of 639 trials
NCT07417605Recruiting

Diagnostic Performance Of 4D Dynamic LAFOV FDG-PET Acquisition for Differentiation of Residual Disease and Post-radiation Inflammation in Head Neck SCC Treated by Radiotherapy.

Role: lead

NCT07514845Completed

First-line Surgical Versus Medical Treatment: A Retrospective Study From 2014 to 2024 in Brest (BRESTE)

Role: lead

NCT05450783Recruiting

Tissue and Metabolic Characterization of Arrhythmogenic Cardiomyopathies by Hybrid PET-MRI Imaging, Impact of the Observed Profiles on the Phenotype and on the Evolution of Cardiomyopathy

Role: collaborator

NCT07189039Completed

Studying Access to Healthcare for Children in the Child Welfare System: the Health of Protected Children

Role: collaborator

NCT07526688Not ApplicableNot Yet Recruiting

Aerobic Physical Activity and Orofacial Myofascial Pain

Role: lead

NCT06919627Completed

Negative HPV Test Results on Infinity/GeneXpert® With the Presence of a Late Amplification Signal: What Does This Mean ? (PaPCR)

Role: lead

NCT07487155Not ApplicableNot Yet Recruiting

Unified Junction of Care, Integrated Treatments and Team Coordination for ADHD in Prison Settings With Substance Use Disorder

Role: lead

NCT05198960Phase 3Recruiting

AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms

Role: lead

NCT07156422Not ApplicableRecruiting

Pathophysiological Study of the Sensitive Scalp

Role: lead

NCT03312075Terminated

Epidemiology and Clinical Characteristics of Non-Tuberculous Mycobacteria Infections in Cystic Fibrosis Patients.

Role: lead

NCT06894602Recruiting

Association of Ultrasonographic Temporal Artery Lesions and Relapse in Patients With Giant Cell Arteritis

Role: lead

NCT04207814Not ApplicableRecruiting

Determinants of Repeated Spontaneous Miscarriages and Unexplained Fetal Deaths

Role: lead

NCT04909606Not ApplicableRecruiting

Evaluation of a Nurse-led Program for the Prevention of Complications of Long-term Corticosteroid Therapy

Role: lead

NCT06045702Recruiting

Establishment of a Primary Epididymal Cell Model From Epididymal Samples to Study CFTR Gene Regulation

Role: lead

NCT03198702Phase 3Recruiting

Effectiveness and Safety of Early Intramuscular Botulinum Toxin Injections to Prevent Shoulder Deformity in Babies With Obstetrical Brachial Plexus Palsy

Role: lead

NCT04785443Phase 3Recruiting

Contribution of ICG Angiography in the Detection of Parathyroids and the Prevention of Hypoparathyroidism Post Total Thyroidectomy

Role: lead

NCT06962215Not ApplicableRecruiting

The Impact of Paramedic Training in Simulation on the Experience of Patients Treated for Malignant Brain Tumors in Neurosurgery (IPSIMANON)

Role: lead

NCT04678167Not ApplicableRecruiting

Boarding Ring Glasses Versus Placebo Glasses or Not Glasses in the Treatment of Vestibular Neuritis

Role: lead

NCT04945278Not ApplicableRecruiting

Study of Self-Recognition and Self/Other Distinction Disorders in Patients With Psychological Vulnerability

Role: lead

NCT05440838Recruiting

Identification of Factors Associated With Treatment Response in Patients With Polycythemia Vera, Essential Thrombocythemia, and Pre-myelofibrosis.

Role: collaborator